Cargando…
Establishing clinically meaningful within-individual improvement thresholds for eight patient-reported outcome measures in people with relapsing-remitting multiple sclerosis
BACKGROUND: As disease-modifying therapies do not reverse the course of multiple sclerosis (MS), assessment of therapeutic success involves documenting patient-reported outcomes (PROs) concerning health-related quality of life, disease and treatment-related symptoms, and the impact of symptoms on fu...
Autores principales: | Greene, Nupur, Quéré, Stéphane, Bury, Denise P., Mazerolle, Flora, M’Hari, Manal, Loubert, Angély, Regnault, Antoine, Higuchi, Keiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319693/ https://www.ncbi.nlm.nih.gov/pubmed/37402086 http://dx.doi.org/10.1186/s41687-023-00594-8 |
Ejemplares similares
-
Medication Adherence and Healthcare Utilization in Relapsing-Remitting Multiple Sclerosis Patients Using Teriflunomide
por: Greene, Nupur, et al.
Publicado: (2022) -
Evaluating the impact of calibration of patient-reported outcomes measures on results from randomized clinical trials: a simulation study based on Rasch measurement theory
por: Loubert, Angély, et al.
Publicado: (2022) -
A toolbox of different approaches to analyze and present PRO-CTCAE data in oncology studies
por: Regnault, Antoine, et al.
Publicado: (2023) -
Is the St. George’s Respiratory Questionnaire an Appropriate Measure of Symptom Severity and Activity Limitations for Clinical Trials in COPD? Analysis of Pooled Data from Five Randomized Clinical Trials
por: Loubert, Angely, et al.
Publicado: (2020) -
PB2184: IMPACT OF TRANSFUSION BURDEN ON HEALTH-RELATED QUALITY OF LIFE AND FUNCTIONING IN PATIENTS WITH MYELOFIBROSIS: POST HOC ANALYSIS OF SIMPLIFY-1 AND -2
por: Mesa, Ruben, et al.
Publicado: (2023)